InterX Technologies

InterX Technologies manufactures FDA-cleared, non-invasive neuromodulation devices for the treatment of acute, post-surgical, and chronic neuropathic pain. The company's primary product line includes the InterX® 5002 (professional) and InterX® 1000 (personal) devices, which deliver interactive neurostimulation directly to the skin without conductive gel. Both devices employ patented flex array impedance-seeking electrode pads and are compatible with multiple electrode accessories, including the newly launched XPad®—a flexible, adhesive, cut-to-fit conductive pad for dynamic muscle groups and high-movement zones. InterX devices are used across clinical, sports medicine, military, and home-care settings. The company serves physical therapists, chiropractors, athletic trainers, healthcare professionals, and individual patients. Markets include professional sports (NFL, NBA, MLB, NHL), U.S. military and Veterans Affairs, academic medical centers (Duke Health, Texas Health), and specialized therapy clinics. All devices and accessories are backed by broad patents and clinical evidence. InterX operates training centers and licensing programs for healthcare professionals. The company ships within the United States only.